# Innovex International, Inc.: overview

INVX · NYSE · CIK 1042893 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/invx.md) · [Financials](/companies/invx/financials.md) · [Filings](/companies/invx/filings.md) · [Insiders](/companies/invx/insiders.md)

Latest reported revenue: [$244.9m](/filings/0001193125-26-332959.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-332959).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [152](/filings/0001193125-25-265003.md) | [251 d](/filings/0001193125-26-067228.md) | [240](/filings/0001193125-26-206528.md) | [224](/filings/0001193125-26-332959.md) | [240](/filings/0001193125-25-265003.md) | [274 d](/filings/0001193125-26-067228.md) | [239](/filings/0001193125-26-206528.md) | [245](/filings/0001193125-26-332959.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(8.7%)](/filings/0001193125-25-265003.md) | [10.7% d](/filings/0001193125-26-067228.md) | [9.1%](/filings/0001193125-26-206528.md) | [10.1%](/filings/0001193125-26-332959.md) | [26.0%](/filings/0001193125-25-265003.md) | [9.4% d](/filings/0001193125-26-067228.md) | [(9.1%)](/filings/0001193125-26-206528.md) | [13.8%](/filings/0001193125-26-332959.md) |
| Net margin | % | [54.4%](/filings/0001193125-25-265003.md) | [12.7% d](/filings/0001193125-26-067228.md) | [6.1%](/filings/0001193125-26-206528.md) | [6.8%](/filings/0001193125-26-332959.md) | [16.3%](/filings/0001193125-25-265003.md) | [5.1% d](/filings/0001193125-26-067228.md) | [(7.0%)](/filings/0001193125-26-206528.md) | [10.2%](/filings/0001193125-26-332959.md) |
| Diluted EPS | $ per share | [1.99](/filings/0001193125-25-265003.md) | not reported | [0.21](/filings/0001193125-26-206528.md) | [0.22](/filings/0001193125-26-332959.md) | [0.57](/filings/0001193125-25-265003.md) | not reported | [(0.24)](/filings/0001193125-26-206528.md) | [0.36](/filings/0001193125-26-332959.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [288](/filings/0000950170-23-005506.md) | [467](/filings/0000950170-25-031003.md) | [556](/filings/0001193125-26-067228.md) | [661](/filings/0001193125-26-067228.md) | [978](/filings/0001193125-26-067228.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(43.5%)](/filings/0000950170-24-082104.md) | [16.2%](/filings/0000950170-25-031003.md) | [17.5%](/filings/0001193125-26-067228.md) | [7.4%](/filings/0001193125-26-067228.md) | [13.6%](/filings/0001193125-26-067228.md) |
| Net margin | % | [(44.6%)](/filings/0000950170-24-082104.md) | [13.5%](/filings/0000950170-25-031003.md) | [13.3%](/filings/0001193125-26-067228.md) | [21.2%](/filings/0001193125-26-067228.md) | [8.5%](/filings/0001193125-26-067228.md) |
| Diluted EPS | $ per share | [(3.63)](/filings/0000950170-24-082104.md) | [2.01](/filings/0000950170-25-031003.md) | [2.29](/filings/0001193125-26-067228.md) | [2.77](/filings/0001193125-26-067228.md) | [1.20](/filings/0001193125-26-067228.md) |
| Free cash flow | $m | [28.4](/filings/0000950170-24-082104.md) | [(24.7)](/filings/0000950170-25-031003.md) | [43.2](/filings/0001193125-26-067228.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/invx/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $160.4m | 6,467,302 |  | Added +429,988 |
| [BRANDES INVESTMENT PARTNERS, LP](/funds/1015079.md) | 2026-06-30 | $142.0m | 5,727,445 |  | Reduced −855,970 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $71.3m | 2,874,572 |  | Added +228,196 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $68.3m | 2,753,070 |  | Added +75,176 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $66.7m | 2,687,950 |  | Reduced −965,436 |
| [Driehaus Capital Management LLC](/funds/938206.md) | 2026-06-30 | $48.6m | 1,958,268 |  | Added +421,959 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $47.3m | 1,907,929 |  | Reduced −23,282 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $46.9m | 1,891,701 |  | Added +175,423 |
| [GAMCO INVESTORS, INC. ET AL](/funds/807249.md) | 2026-06-30 | $42.4m | 1,709,798 |  | Reduced −24,895 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $30.2m | 1,218,242 |  | Reduced −100,873 |

## Recent filings

[All 1,050 filings](/companies/invx/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 17:46 ET | [SCHEDULE 13D/A](/filings/0001011438-26-000481.md) | Ownership report, active investor, amended | 0001011438-26-000481 |
| 2026-08-10 | 16:47 ET | [8-K](/filings/0001193125-26-342567.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-342567 |
| 2026-08-04 | 16:34 ET | [10-Q](/filings/0001193125-26-332959.md) | Quarterly report, period 2026-06-30 | 0001193125-26-332959 |
| 2026-08-03 | 16:37 ET | [8-K](/filings/0001193125-26-330695.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-330695 |
| 2026-07-01 | 17:00 ET | [8-K/A](/filings/0001193125-26-292774.md) | 3.02 Unregistered sale of equity | 0001193125-26-292774 |
| 2026-06-15 | 07:30 ET | [8-K](/filings/0001193125-26-270295.md) | 3.02 Unregistered sale of equity | 0001193125-26-270295 |
| 2026-05-11 | 16:30 ET | [8-K](/filings/0001193125-26-216895.md) | 5.07 Shareholder vote results | 0001193125-26-216895 |
| 2026-05-05 | 16:29 ET | [10-Q](/filings/0001193125-26-206528.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206528 |
| 2026-05-04 | 16:30 ET | [8-K](/filings/0001193125-26-204105.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-204105 |
| 2026-03-27 | 16:30 ET | [DEF 14A](/filings/0001193125-26-129169.md) | Proxy statement, period 2026-03-27 | 0001193125-26-129169 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-067228.md), filed Feb 24, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/efbde301-9745-4931-85d7-eeacf305b547)

## About the filer

- CIK: 1042893
- Tickers: INVX
- Exchange: NYSE
- SIC code: 3533 Oil & Gas Field Machinery & Equipment
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 16:21 ET. No prices; not investment advice.